Lili Zhao

18.8k total citations · 3 hit papers
389 papers, 11.2k citations indexed

About

Lili Zhao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lili Zhao has authored 389 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 97 papers in Oncology and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lili Zhao's work include Cancer Immunotherapy and Biomarkers (22 papers), Cancer Genomics and Diagnostics (20 papers) and Lung Cancer Treatments and Mutations (19 papers). Lili Zhao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Cancer Genomics and Diagnostics (20 papers) and Lung Cancer Treatments and Mutations (19 papers). Lili Zhao collaborates with scholars based in United States, China and Japan. Lili Zhao's co-authors include Weiping Zou, Ilona Kryczek, Linda Vatan, Wojciech Szeliga, Shuang Wei, Theodore S. Lawrence, Ende Zhao, Meredith A. Morgan, Dongjun Peng and Harry L. T. Mobley and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lili Zhao

363 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

2015 893 citations Dongjun Peng, Ilona Kryczek et al. profile →
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

2017 579 citations Shuang Wei, Lili Zhao et al. profile →
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

2018 449 citations Shuang Wei, Lili Zhao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lili Zhao United States	49	4.6k	4.1k	2.5k	1.6k	1.4k	389	11.2k
Hong Zhao China	59	4.7k 1.0×	3.9k 0.9×	2.9k 1.2×	1.7k 1.1×	1.4k 1.0×	273	12.5k
Xuelei Ma China	48	3.7k 0.8×	3.4k 0.8×	1.6k 0.7×	1.7k 1.1×	1.9k 1.4×	313	10.5k
Alice P. Chen United States	50	4.7k 1.0×	4.4k 1.1×	1.2k 0.5×	2.8k 1.7×	2.0k 1.5×	310	11.2k
David R. Spriggs United States	62	4.2k 0.9×	4.9k 1.2×	3.0k 1.2×	1.2k 0.8×	1.9k 1.4×	230	13.0k
Douglas M. Noonan Italy	66	6.0k 1.3×	3.3k 0.8×	3.0k 1.2×	2.1k 1.3×	741 0.5×	245	13.7k
Michèle Milella Italy	54	5.6k 1.2×	6.5k 1.6×	1.5k 0.6×	2.5k 1.6×	2.5k 1.8×	370	12.9k
Shahab Uddin Qatar	69	7.9k 1.7×	5.0k 1.2×	3.5k 1.4×	2.8k 1.7×	845 0.6×	385	15.1k
Jianjun Gao China	41	3.1k 0.7×	3.5k 0.8×	2.1k 0.8×	1.2k 0.7×	1.6k 1.2×	260	10.6k
Massimo Libra Italy	68	8.5k 1.8×	4.4k 1.1×	1.8k 0.7×	3.2k 2.0×	1.8k 1.3×	290	15.9k
Yuanyuan Zhang China	41	4.5k 1.0×	4.5k 1.1×	4.3k 1.7×	2.3k 1.4×	1.5k 1.1×	256	11.1k

Countries citing papers authored by Lili Zhao

Since Specialization

Citations

This map shows the geographic impact of Lili Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Zhao more than expected).

Fields of papers citing papers by Lili Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Zhao. The network helps show where Lili Zhao may publish in the future.

Co-authorship network of co-authors of Lili Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Zhao. A scholar is included among the top collaborators of Lili Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Zhao. Lili Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapper, Elliot B., Samantha Nikirk, Donna M. Evon, et al.. (2025). LIVE-SMART: A sequential, multiple assignment randomized trial to reduce falls in cirrhosis. Hepatology Communications. 9(3).

Murdock, Benjamin J., et al.. (2025). In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics. Annals of Clinical and Translational Neurology. 12(10). 2036–2044. 1 indexed citations

Li, Bo, Jing Zhang, Yu Yin, et al.. (2024). Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo. Frontiers of Medicine. 18(5). 896–910.

Ang, Lynn, Yiyuan Huang, Catherine L. Martin, et al.. (2024). Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes. Journal of the American Heart Association. 14(1). e036787–e036787. 2 indexed citations

Song, Dingli, et al.. (2023). Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma. Cancer Cell International. 23(1). 322–322. 3 indexed citations

Comba, Andrea, Patrick Dunn, Padma Kadiyala, et al.. (2020). Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses. Neuro-Oncology. 22(6). 806–818. 38 indexed citations

Alghamri, Mahmoud S., Ali Dabaja, Ayman Taher, et al.. (2020). Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-Oncology Advances. 2(1). vdaa042–vdaa042. 17 indexed citations

Wannachalee, Taweesak, Lili Zhao, Kazutaka Nanba, et al.. (2019). Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling. The Journal of Clinical Endocrinology & Metabolism. 104(12). 5867–5876. 46 indexed citations

Zhang, Guilian, et al.. (2018). The Role of Blood-Brain Barrier Damage in the Pathogenesis of Contrast-Induced Encephalopathy.. 2(2). 34–40. 5 indexed citations

10.

Murlidhar, Vasudha, Rishindra M. Reddy, Shamileh Fouladdel, et al.. (2017). Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. Cancer Research. 77(18). 5194–5206. 139 indexed citations

11.

Skala, Stephanie L., David Arps, Lili Zhao, et al.. (2017). Comprehensive histopathological comparison of epidermotropic/dermal metastatic melanoma and primary nodular melanoma. Histopathology. 72(3). 472–480. 10 indexed citations

12.

Wahl, Daniel, Joseph Dresser, Kari Wilder-Romans, et al.. (2016). Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis. Cancer Research. 77(4). 960–970. 67 indexed citations

13.

Nagarsheth, Nisha, Dongjun Peng, Ilona Kryczek, et al.. (2015). PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Research. 76(2). 275–282. 213 indexed citations

14.

Jiang, Yan, Zora Djurić, Ananda Sen, et al.. (2014). Biomarkers for Personalizing Omega-3 Fatty Acid Dosing. Cancer Prevention Research. 7(10). 1011–1022. 16 indexed citations

15.

Karnak, David, Carl G. Engelke, Leslie A. Parsels, et al.. (2014). Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer. Clinical Cancer Research. 20(19). 5085–5096. 125 indexed citations

16.

Engelke, Carl G., Leslie A. Parsels, Yushen Qian, et al.. (2013). Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776. Clinical Cancer Research. 19(16). 4412–4421. 89 indexed citations

17.

Wei, Dongping, Hua Li, Jie Yu, et al.. (2011). Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor. Cancer Research. 72(1). 282–293. 136 indexed citations

18.

Parsels, Leslie A., Yushen Qian, Daria M. Tanska, et al.. (2011). Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition. Clinical Cancer Research. 17(11). 3706–3715. 67 indexed citations

19.

Morgan, Meredith A., Leslie A. Parsels, Lili Zhao, et al.. (2010). Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair. Cancer Research. 70(12). 4972–4981. 249 indexed citations

20.

Chen, Guoan, So Hee Kim, Amanda N. King, et al.. (2010). CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma. Clinical Cancer Research. 17(4). 817–826. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact